Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures

Objective: This study aimed to determine the effect of reperfusion therapies on the occurrence of early post-stroke seizures (PSS) in patients with acute ischemic stroke (AIS).Background: Reperfusion therapies are paramount to the treatment of stroke in the acute phase. However, their effect on the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tasnim Mushannen, Rozaleen Aleyadeh, Maria Siddiqui, Maher Saqqur, Naveed Akhtar, Boulenouar Mesraoua, Salman Al Jerdi, Gayane Melikyan, Yanal Shaheen, Haneen Qadourah, Odette Chagoury, Ziyad R. Mahfoud, Naim Haddad
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/75f83d24b9e1434db9a8783ff294c359
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:75f83d24b9e1434db9a8783ff294c359
record_format dspace
spelling oai:doaj.org-article:75f83d24b9e1434db9a8783ff294c3592021-11-22T04:28:39ZEffect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures1664-229510.3389/fneur.2021.758181https://doaj.org/article/75f83d24b9e1434db9a8783ff294c3592021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.758181/fullhttps://doaj.org/toc/1664-2295Objective: This study aimed to determine the effect of reperfusion therapies on the occurrence of early post-stroke seizures (PSS) in patients with acute ischemic stroke (AIS).Background: Reperfusion therapies are paramount to the treatment of stroke in the acute phase. However, their effect on the incidence of early seizures after an AIS remains unclear.Design and Methods: The stroke database at Hamad Medical Corporation was used to identify all patients who received reperfusion therapies for AIS from 2016 to 2019. They were matched with patients of similar diagnosis, gender, age, and stroke severity as measured by National Institutes of Health Stroke Scale (NIHSS) who did not receive such treatment. The rates of early PSS were calculated for each group.Results: The results showed that 508 patients received reperfusion therapies (342 had IV thrombolysis only, 70 had thrombectomies only, and 96 had received both), compared with 501 matched patients receiving standard stroke unit care. Patients who received reperfusion therapies were similar to their matched controls for mean admission NIHSS score (9.87 vs. 9.79; p = 0.831), mean age (53.3 vs. 53.2 years; p = 0.849), and gender distribution (85 vs. 86% men; p = 0.655). The group receiving reperfusion therapies was found to have increased stroke cortical involvement (62 vs. 49.3%, p < 0.001) and hemorrhagic transformation rates (33.5 vs. 18.6%, p < 0.001) compared with the control group. The rate of early PSS was significantly lower in patients who received reperfusion therapies compared with those who did not (3.1 vs. 5.8%, respectively; p = 0.042). When we excluded seizures occurring at stroke onset prior to any potential treatment implementation, the difference in early PSS rates between the two groups was no longer significant (2.6 vs. 3.9%, respectively; p = 0.251). There was no significant difference in early PSS rate based on the type of reperfusion therapy either (3.2% with thrombolysis, 2.9% with thrombectomy, and 3.1% for the combined treatment, p = 0.309).Conclusions: Treatment of AIS with either thrombectomy, thrombolysis, or both does not increase the risk of early PSS.Tasnim MushannenRozaleen AleyadehMaria SiddiquiMaher SaqqurMaher SaqqurNaveed AkhtarBoulenouar MesraouaBoulenouar MesraouaSalman Al JerdiSalman Al JerdiGayane MelikyanGayane MelikyanYanal ShaheenHaneen QadourahOdette ChagouryOdette ChagouryZiyad R. MahfoudNaim HaddadNaim HaddadFrontiers Media S.A.articlereperfusion therapiesstrokeearly post-stroke seizuresthrombolysismechanical thrombectomysymptomatic seizuresNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic reperfusion therapies
stroke
early post-stroke seizures
thrombolysis
mechanical thrombectomy
symptomatic seizures
Neurology. Diseases of the nervous system
RC346-429
spellingShingle reperfusion therapies
stroke
early post-stroke seizures
thrombolysis
mechanical thrombectomy
symptomatic seizures
Neurology. Diseases of the nervous system
RC346-429
Tasnim Mushannen
Rozaleen Aleyadeh
Maria Siddiqui
Maher Saqqur
Maher Saqqur
Naveed Akhtar
Boulenouar Mesraoua
Boulenouar Mesraoua
Salman Al Jerdi
Salman Al Jerdi
Gayane Melikyan
Gayane Melikyan
Yanal Shaheen
Haneen Qadourah
Odette Chagoury
Odette Chagoury
Ziyad R. Mahfoud
Naim Haddad
Naim Haddad
Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures
description Objective: This study aimed to determine the effect of reperfusion therapies on the occurrence of early post-stroke seizures (PSS) in patients with acute ischemic stroke (AIS).Background: Reperfusion therapies are paramount to the treatment of stroke in the acute phase. However, their effect on the incidence of early seizures after an AIS remains unclear.Design and Methods: The stroke database at Hamad Medical Corporation was used to identify all patients who received reperfusion therapies for AIS from 2016 to 2019. They were matched with patients of similar diagnosis, gender, age, and stroke severity as measured by National Institutes of Health Stroke Scale (NIHSS) who did not receive such treatment. The rates of early PSS were calculated for each group.Results: The results showed that 508 patients received reperfusion therapies (342 had IV thrombolysis only, 70 had thrombectomies only, and 96 had received both), compared with 501 matched patients receiving standard stroke unit care. Patients who received reperfusion therapies were similar to their matched controls for mean admission NIHSS score (9.87 vs. 9.79; p = 0.831), mean age (53.3 vs. 53.2 years; p = 0.849), and gender distribution (85 vs. 86% men; p = 0.655). The group receiving reperfusion therapies was found to have increased stroke cortical involvement (62 vs. 49.3%, p < 0.001) and hemorrhagic transformation rates (33.5 vs. 18.6%, p < 0.001) compared with the control group. The rate of early PSS was significantly lower in patients who received reperfusion therapies compared with those who did not (3.1 vs. 5.8%, respectively; p = 0.042). When we excluded seizures occurring at stroke onset prior to any potential treatment implementation, the difference in early PSS rates between the two groups was no longer significant (2.6 vs. 3.9%, respectively; p = 0.251). There was no significant difference in early PSS rate based on the type of reperfusion therapy either (3.2% with thrombolysis, 2.9% with thrombectomy, and 3.1% for the combined treatment, p = 0.309).Conclusions: Treatment of AIS with either thrombectomy, thrombolysis, or both does not increase the risk of early PSS.
format article
author Tasnim Mushannen
Rozaleen Aleyadeh
Maria Siddiqui
Maher Saqqur
Maher Saqqur
Naveed Akhtar
Boulenouar Mesraoua
Boulenouar Mesraoua
Salman Al Jerdi
Salman Al Jerdi
Gayane Melikyan
Gayane Melikyan
Yanal Shaheen
Haneen Qadourah
Odette Chagoury
Odette Chagoury
Ziyad R. Mahfoud
Naim Haddad
Naim Haddad
author_facet Tasnim Mushannen
Rozaleen Aleyadeh
Maria Siddiqui
Maher Saqqur
Maher Saqqur
Naveed Akhtar
Boulenouar Mesraoua
Boulenouar Mesraoua
Salman Al Jerdi
Salman Al Jerdi
Gayane Melikyan
Gayane Melikyan
Yanal Shaheen
Haneen Qadourah
Odette Chagoury
Odette Chagoury
Ziyad R. Mahfoud
Naim Haddad
Naim Haddad
author_sort Tasnim Mushannen
title Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures
title_short Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures
title_full Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures
title_fullStr Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures
title_full_unstemmed Effect of Reperfusion Therapies on Incidence of Early Post-Stroke Seizures
title_sort effect of reperfusion therapies on incidence of early post-stroke seizures
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/75f83d24b9e1434db9a8783ff294c359
work_keys_str_mv AT tasnimmushannen effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT rozaleenaleyadeh effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT mariasiddiqui effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT mahersaqqur effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT mahersaqqur effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT naveedakhtar effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT boulenouarmesraoua effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT boulenouarmesraoua effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT salmanaljerdi effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT salmanaljerdi effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT gayanemelikyan effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT gayanemelikyan effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT yanalshaheen effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT haneenqadourah effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT odettechagoury effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT odettechagoury effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT ziyadrmahfoud effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT naimhaddad effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
AT naimhaddad effectofreperfusiontherapiesonincidenceofearlypoststrokeseizures
_version_ 1718418168005787648